Pfizer
PFE
PFE
2,924 hedge funds and large institutions have $114B invested in Pfizer in 2023 Q4 according to their latest regulatory filings, with 324 funds opening new positions, 864 increasing their positions, 1,584 reducing their positions, and 269 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less funds holding in top 10
Funds holding in top 10: 52 → 39 (-13)
29% less call options, than puts
Call options by funds: $2.49B | Put options by funds: $3.5B
45% less repeat investments, than reductions
Existing positions increased: 864 | Existing positions reduced: 1,584
Holders
2,924
Holding in Top 10
39
Calls
$2.49B
Puts
$3.5B
Top Buyers
| 1 | +$2.4B | |
| 2 | +$336M | |
| 3 | +$331M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$282M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$256M |
Top Sellers
| 1 | -$558M | |
| 2 | -$300M | |
| 3 | -$266M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$262M |
| 5 |
Two Sigma Investments
New York
|
-$232M |